Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it ...

Cytological evaluation of the peritoneal fluid showed that it predominantly consisted of lymphocytes, macrophages, and reactive mesothelial cells; few neutrophils were present in the fluid (Fig.